TD Waterhouse Canada’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$990K Buy
5,797
+900
+18% +$97.9K ﹤0.01% 706
2026
Q1
$591K Buy
4,897
+41
+0.8% +$4.12K ﹤0.01% 809
2025
Q4
$496K Sell
4,856
-35
-0.7% -$3.13K ﹤0.01% 697
2025
Q3
$306K Buy
4,891
+151
+3% +$8.21K ﹤0.01% 786
2025
Q2
$240K Buy
4,740
+1,851
+64% +$82.7K ﹤0.01% 790
2025
Q1
$123K Sell
2,889
-40
-1% -$1.73K ﹤0.01% 895
2024
Q4
$89.5K Buy
2,929
+1,634
+126% +$46K ﹤0.01% 964
2024
Q3
$28.6K Hold
1,295
﹤0.01% 1167
2024
Q2
$36.6K Buy
+1,295
New +$30.2K ﹤0.01% 1088
2024
Q1
Sell
-1
Closed -$26 1831
2023
Q4
$26 Sell
1
-30
-97% -$787 ﹤0.01% 1689
2023
Q3
$1.23K Hold
31
﹤0.01% 1538
2023
Q2
$1.46K Buy
31
+1
+3% +$29 ﹤0.01% 1573
2023
Q1
$971 Hold
30
﹤0.01% 1598
2022
Q4
$1.11K Hold
30
﹤0.01% 1549
2022
Q3
$2.24K Hold
30
﹤0.01% 1493
2022
Q2
$1.69K Sell
30
-31,161
-100% -$1.54M ﹤0.01% 1558
2022
Q1
$2.34M Buy
31,191
+2,477
+9% +$170K 0.02% 318
2021
Q4
$2.89M Buy
+28,714
New +$2.97M 0.03% 307

Other funds holding GH

TD Waterhouse Canada's GH Position: Q2 2026 in Review

TD Waterhouse Canada increased its Guardant Health (GH) stake by 18% in Q2 2026, buying an estimated $97.9K and bringing the position to 5,797 shares worth $990K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

TD Waterhouse Canada first reported a position in GH in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.89M in Q4 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • TD Waterhouse Canada held 5,797 shares of Guardant Health worth $990K as of Q2 2026.
  • TD Waterhouse Canada bought 900 Guardant Health shares in Q2 2026, an estimated $97.9K.
  • Guardant Health made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #706 holding.
  • TD Waterhouse Canada first reported a position in Guardant Health in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Guardant Health position peaked at $2.89M in Q4 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.